In the last trading session, 11.54 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.55. Most recently the company’s share price was $2.39, and it changed around $0.9 or 60.40% from the last close, which brings the market valuation of the company to $151.26M. GALT currently trades at a discount to its 52-week high of $3.17, offering almost -32.64% off that amount. The share price’s 52-week low was $0.73, which indicates that the current value has risen by an impressive 69.46% since then. We note from Galectin Therapeutics Inc’s average daily trading volume that its 10-day average is 1.34 million shares, with the 3-month average coming to 212.87K.
Galectin Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended GALT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Galectin Therapeutics Inc (NASDAQ:GALT) trade information
Instantly GALT has showed a green trend with a performance of 60.40% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.7900 on recent trading dayincreased the stock’s daily price by 14.34%. The company’s shares are currently up 85.27% year-to-date, but still up 78.36% over the last five days. On the other hand, Galectin Therapeutics Inc (NASDAQ:GALT) is 86.72% up in the 30-day period. We can see from the shorts that 8.9 million shares have been sold at a short interest cover period of 52.08 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -23.89%. Galectin Therapeutics Inc earnings are expected to increase by 11.84% in 2025, but the outlook is positive 5.57% per year for the next five years.
GALT Dividends
Galectin Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-14.
BLACKROCK INC., with 2.5128% or 1.56 million shares worth $3.53 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
